L614-0131 Screening compound: 1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide

L614-0131 Screening compound: 1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide
L614-0131 Screening compound: 1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L614-0131
1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L614-0131

Molecular Formula

C22H27N3O6S (C22 H27 N3 O6 S)

Compound Name

1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide

IUPAC name

1-[4-(4-methoxybenzenesulfonamido)benzoyl]-N-(2-methoxyethyl)pyrrolidine-2-carboxamide

SMILES

COCCNC(C(CCC1)N1C(c(cc1)ccc1NS(c(cc1)ccc1OC)(=O)=O)=O)=O

InChI

InChI=1S/C22H27N3O6S/c1-30-15-13-23-21(26)20-4-3-14-25(20)22(27)16-5-7-17(8-6-16)24-32(28,29)19-11-9-18(31-2)10-12-19/h5-12,20,24H,3-4,13-15H2,1-2H3,(H,23,26)/t20-/m0/s1

InChI Key

RWSOQQMDEFAVQQ-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27466042

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.54

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.708

Distribution Coefficient, logD

1.504

Water Solubility, LogSw

-2.66

Polar Surface Area

98.009

Acid Dissociation Constant (pKa)

7.62

Base Dissociation Constant (pKb)

-0.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

L614-0131 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L614-0131 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L614-0131?
Check Price and Availability of L614-0131, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L614-0131 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L614-0131
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L614-0131
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L614-0131 available by request